Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Transferable Immunoglobulin A–Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation

Gastroenterology(2021)10.1053/j.gastro.2021.09.061Source: DataRank Database

Transferable Immunoglobulin A–Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation is a research paper published in Gastroenterology (2021). On theSindex it has a DataRank of 4.4. It has been cited 159 times, with 100 citing works in its 1-hop citation network.

N/A

4.4DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access159 citations · 100 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT02516384

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 6.22)OA: greenTopics (72)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 17%Citation Network 83%

Base Score Contribution

0.761

From this paper's citation signal

Citation Network Contribution

3.6

From 100 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 100 citers.

Modulating gut microbiota in autoimmune diseases: a cutting-edge strategy from prophylaxis to therapeutics
Science Bulletin202115 citations15 referencesContributes 0.185
Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients
Journal of Clinical Biochemistry and Nutrition202317 citations23 referencesContributes 0.126
Metagenomics for IgA-coated gut microbiota: from taxonomy to function
Trends in Microbiology20255 citations15 referencesContributes 0.119
Multi-omics analysis reveals therapeutic effects of Bacillus subtilis-fermented Astragalus membranaceus in hyperuricemia via modulation of gut microbiota
Food Chemistry202267 citations42 referencesContributes 0.100
Microbial determinants of effective donors in faecal microbiota transplantation for UC
Gut202254 citations40 referencesContributes 0.100

Authors (15)

Lasha Gogokhia ORCID,Monica Viladomiu,Lance Chou,Gregory Putzel ORCID,Wen‐Bing Jin ORCID

Live enrichment

PubMed:34606847 PMC:PMC8678328 OpenAlex:https://openalex.org/W3202490198

National Institutes of Health

Grant: R01DK114252

National Institutes of Health

Grant: DK128257

NIDDK NIH HHS

Grant: R01 DK128257

Crohn's & Colitis Foundation

Grant: 624876

NIDDK NIH HHS

Grant: R01 DK120985

Kenneth Rainin Foundation

Grant: KRA000028

Kenneth Rainin foundation

Boehringer Ingelheim

FWCI

6.22

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8678328

publisherhttps://api.elsevier.com/content/article/PII:S0016508521036106?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0016508521036106?httpAccept=text/plain

journalhttps://doi.org/10.1053/j.gastro.2021.09.061

Fields of Study

Gut microbiota and healthClostridium difficile and Clostridium perfringens researchProbiotics and Fermented FoodsAnimalsBacteroidetesClinical Trials as TopicColitisColitis, UlcerativeColonDisease Models, AnimalFecal Microbiota TransplantationForkhead Transcription FactorsGastrointestinal MicrobiomeGerm-Free LifeHumansImmunity, MucosalImmunoglobulin AIntestinal MucosaIntraepithelial LymphocytesMetagenomeMetagenomicsMice, Inbred C57BLMice, KnockoutNuclear Receptor Subfamily 1, Group F, Member 3T-Lymphocytes, RegulatoryTreatment OutcomeMiceOdoribacter splanchnicus

MeSH Terms

Gastrointestinal MicrobiomeFecal Microbiota TransplantationIntraepithelial LymphocytesAnimalsClinical Trials as TopicColitisColitis, UlcerativeColonDisease Models, AnimalGerm-Free LifeHumansImmunoglobulin AIntestinal MucosaMice, Inbred C57BLTreatment OutcomeMice, KnockoutImmunity, MucosalBacteroidetesT-Lymphocytes, RegulatoryMiceForkhead Transcription FactorsMetagenomeMetagenomicsNuclear Receptor Subfamily 1, Group F, Member 3

Keywords

Fecal bacteriotherapyUlcerative colitisAntibodyFecesInflammationMedicineImmunoglobulin ATransplantationColitisImmunologyGastroenterologyImmunoglobulin GInternal medicineMicrobiologyBiologyDiseaseClostridium difficileFecal Microbiota TransplantOdoribacterIga-seq

Sustainable Development Goals

SDG 0: Good health and well-being